SANOFI (CHINA) INVESTMENT CO., LTD. SHANGHAI BRANCH;SHANGHAI JIAO TONG UNIVERSITY
发明人:
DAWEI LI,DHAIHIRI S. MASHAUSI,HAO GUO,QI ZHU,ZHENGHUA WU
申请号：
BR112014000181
公开号：
BR112014000181A2
申请日:
2012.07.05
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract disclosed is an agr2 blocking monoclonal antibody, and in particular a humanized monoclonal antibody for blocking agr2. also disclosed is a pharmaceutical composition containing the antibody and a method for preparing the same, and a use of the antibody in blocking tumor growth and metastasis. Translation of the Summary Patent Summary: "Agr2 Antibody Blocking and Use". The present invention relates to an agr2 blocking monoclonal antibody, and in particular a humanized monoclonal antibody to block agr2. Also disclosed is a pharmaceutical composition containing the antibody and a method for preparing it, as well as the use of the antibody to block tumor growth and metastasis. 4/3 ws / docs / csa p202591 / report / 20156647v1abstract disclosed is an agr2 blocking monoclonal antibody, and in particular, a humanized monoclonal antibody for blocking agr2. also disclosed is a pharmaceutical composition containing the antibody and a method for preparing the same, and a use of the antibody in blocking tumor growth and metastasis. tradução do resumo resumo patente de invenção: "bloqueamento de anticorpo agr2 e uso dos mesmos". a presente invenção refere-se a um anticorpo monoclonal bloqueador agr2, e em particular, um anticorpo monoclonal humanizado para bloquear agr2. também é descrita uma composição farmacêutica contendo o anticorpo e um método para a preparação dos mesmos, bem como a utilização do anticorpo para bloquear o crescimento de tumores e metástase. 4/3 ws/docs/csa p202591/relatorio/20156647v1
